BIO CEO 2011 Participating Investors

  • Recommend
  • Tweet
  • Print
  • Email

The following is a list of investors from last year's, 13th Annual BIO CEO & Investor Conference. To learn more about investor registration, click here.

Abbott Biotech Ventures
Aceras BioMedical LLC
Actin Biomed
Adams Capital Management
Affirmed Healthcare Capital
AGS Capital Group
Aisling Capital
Akana Capital
AM Investment Partners
AM Pappas & Associates
AMK Capital Services
Apellas Investment Management, LP
Arcus Ventures
Array Capital Management
Ascent Biomedical Holdings
Asian Healthcare Fund
Aspire Capital
Athena Ventures
Atlantic Capital Group
Atlas Venture
Atypical BioCapital Management, LLC
Auriga USA
Bailard Investments
BAM Capital
Bank of America/Merrill Lynch Global Research
Barclays
Bay City Capital
BDR Research Group, LLC.
Beck, Mack & Oliver, LLC.
Bio*One Capital
Biotechnology Value Fund
Black Diamond
BladeRock Capital
Bloom Burton & Co.
Blue Harbour Group
BMO Capital Markets
Boston Life Science Venture Corp.
Brean Murray
Brencourt Advisors, LLC.
Brighton Capital, Ltd.
Broadfin Capital
BSI Healthcapital
Burnham Securities
Burrage Capital
Burrill & Company
Canaccord Genuity
Capstone Investments
Carr Securities
Catapult Capital
Cato BioVentures
Caxton Advantage
Celtic Therapeutics
Centurion
Citadel (Surveyor Capital)
CK Cooper
Columbia University
Conative Capital Management, LLC.
Cowen Healthcare Royal Partners
Credit Suisse
Cross Current Research, LLC.
Dabar Investment Associates
Dawson James Securities
Delwar Capital
Easton Capital Investment Group
Edison Investment Research
EGB Advisors, LLC.
Emerald Advisers
EmergentRx, LLC.
Eminent Venture Capital Corporation
Esae Capital Partners
EuclidSR Partners, L.P.
Fairwater Advisors, LLC
Favus Institutional Research, LLC.
Federated Kaufmann Fund
FIC Capital
Fidelity Biosciences
Flagship Ventures
Fountain Healthcare Partners
Galleon Group
GAMCO Investors, Inc.
George Weiss Associates
Gillon Tax Advisors, LLC.
Gleacher & Co.
Global Emerging Markets Group
Goldman Sachs
Green Arrow Capital Management
Griffin Securities, Inc.
GRT Capital
HAP Capital
Harbor Watch Capital Management
Hercules Growth Capital
Horizon Asset Management
Horizon Technology Finance
Icahn Associates
Iguana Healthcare Partners
Ingalls & Synder, LLC.
Interwest Partners
J Goldman & Co.
J.P. Morgan
JAFCO Life Science Investment
Jeffries & Company
Jina Ventures, Inc.
JMP Securities
Johnston Associates Inc.
Kearny Venture Partners
Keiretsu Forum NY Tri-State
Kingsbridge
Kingsbrook Partners, LP.
Klausner Management
KOM Capital Management, LLC.
Ladenburg Thalmann
Lazard Capital Market
Leerink Swann
LifeSci Advisors
Lincoln Park Capital
Liss Investments LP
Little Gem Life Sciences Fund
Loeb Partners
M3 Capital
Maryland Biotechnology Center
Maxim Group
Mayfair Capital Partners, Inc.
Maz Parnters
McNicoll, Lewis & Vlak
MDB Capital Group
Meadowvale
Medical Strategy
MedImmune Ventures
Mehta Partners
Merlin Nexus
Metro Capital Ventures
MidCap Financial
Miller Tabak
Mitsui & Co. Global Investment, Inc.
Monness, Crespi, Hardt & Co.
Morgan Stanley
MP Healthcare Venture Management
MSMB Capital Management, LLC.
Muse Capital, LLP
MVP Capital Partners
National Securities
Needham
New Enterprise Associates
New Leaf Venture Partners
Newstar Ventures, Ltd.
NGN Capital
NJ Investment Division
Noble Financial Group, Inc.
Numoda Capital Innovations, LLC.
NYSTAR / SBTIF
Omni Capital Corporation
Opus Point Partners
Oracle Investment Management
OrbiMed Advisors, LLC.
Outer Islands Capital
Oxford Finance Corporation
Pacific Rim Ventures
Paisley and Habermas, Inc.
Pappas Ventures
Paul Capital
Pearl Street Venture Funds
Perceptive Advisors
Pfizer
Phase4 Ventures
Pioneer Investments
Piper Jaffray
PolyTechnos Venture-Partners
POSCO BioVentures
Prime Equity Research
Pytho Partners Asia
QuestRion
Quogue Capital, LLC.
QVT Financial
RB Milestone Group
RBC Capital Markets
Redmile Group
Redwood Partners
Revach Fund, LP.
Riverfront Investment Group
Roosevelt Capital Partners, LLC.
ROTH Capital Partners
Royalty Pharma
RRC
Sabretooth Capital
SAC Capital
Safegaurd Scientific Inc.
Sagres Partners
Samtheo Biopharma, LLC
Sanford Bernstein
Saturna Capital
SCO Capital Partners
Second Line Capital Management
Sectoral Asset Management
Serrado Capital
Simrx Advisors
Sio Capital Managmeent
Sivik Global Healthcare
Skyline Ventures
Socius Capital Group
Soleil Securities
Sophrosyne Capital
Special Situations Funds
Spencer Trask Ventures
SpringTree Global Investors
SR One
Standard & Poor's Equity Group
Stanphyl Capital Management
Stansberry Research
Sterling Atlantic, LLC.
Strauss Asset Management
Sumitomo Corporation of America
Symmetry Capital
Symphony Capital
Syzygy Therapeutics
Tang Capital Management, LLC
Tavistock Life Sciences
Technological & Investment Horizons
The Channel Group
The Invus Group
The Keiser Foundation
ThinkEquity, LLC
Thomas, McNereny & Partners
Three Fields Capital
TLF Capital
Tocqueville Asset Management
Trellus Management
Trilogy Global Advisors
TriplePoint Capital
TriState Ventures
Tryphon
Turner Investments
Valquest Capital Management
Van Leeuwenhoeck Institute
VenBio
Venrock
Veziris Venture
Vision Capital Advisors
Visium Asset Management, LP
Warburg Pincus
WBB Securities, LLC
Wedbush PacGrow Life Science
Weiss Multi-Strategy Advisors
Wells Fargo Securities
Western Technology Investment
Wexford Capital, LP.
WJB Capital
WM Smith & Co.
Wolf Capital Management
World Tech Ventures, LLC.
Xmark Opportunity Partners
Yasuda Enterprise Development
Young Capital Partners